Convergent systemic therapy for liver metastases: Bridging primary tumor heterogeneity through shared pathways

Area of Science:

• Oncology
• Hepatobiliary Medicine
• Cancer Biology

Background:

• Liver metastases are a critical indicator of advanced cancer, posing complex management challenges.
• Despite diverse primary origins (colorectal, pancreatic, breast), liver metastases share biological behaviors influenced by the liver's unique microenvironment.
• The immunosuppressive nature of the liver microenvironment impacts metastatic progression and treatment response.

Purpose of the Study:

• To synthesize recent advances in systemic, locoregional, and surgical therapies for liver metastases.
• To explore how shared biological mechanisms can inform unified treatment strategies.
• To propose a precision convergence paradigm for harmonizing cancer therapies.

Main Methods:

• Literature review synthesizing current research on liver metastases treatments.
• Analysis of shared biological mechanisms across different primary tumor types.
• Examination of multidisciplinary approaches and treatment optimization.

Main Results:

• Shared biological mechanisms enable unified therapeutic strategies, including targeted agents and combined immunotherapy-radiotherapy.
• Balancing locoregional and systemic treatments is crucial for converting unresectable cases.
• Multidisciplinary collaboration is essential for personalized treatment planning.

Conclusions:

• A precision convergence approach, guided by 'commonalities in biology, divergences in context,' offers a new paradigm for liver metastases management.
• Harmonizing therapies with lineage-specific adjustments can improve outcomes for patients with liver metastases.
• Integrated treatment strategies are key to improving survival rates in advanced liver cancer.